{
  "figure_1": "Conceptual multilevel framework for investigating, understanding, and addressing disparities in hematologic cancers (3, 4, 14, 15, 40–43). *, Potential funding agencies include the American Association for Cancer Research, American Society of Hematology, Lymphoma Research Foundation, and Multiple Myeloma Research Foundation.",
  "figure_2": "PRISMA flow diagram to identify prospective studies of health disparities in hematologic malignancies. *, One study was common to both leukemia and lymphoma and counted once in the total count. The structured review used the Medical Subject Heading (MeSH) terms (“health status disparities,” or “socioeconomic disparities in health,” or “healthcare disparities”) and the disease terms (“neoplasms, plasma cell,” “leukemia,” or “lymphoma”).",
  "figure_3": "Collaborative model for addressing health disparities. ‡, Investigators need to address unique characteristics of hematologic malignancies in underrepresented populations via experimental and clinical trials. **, Data sharing and patient and student/trainee outreach and retention. *, Engage in care delivery (e.g., home health assistance and visiting nurses, remote clinical trials, transport provision); increased communication with patients (e.g., text messaging, email, phone, or paper); account for patient experience in process and trial design. #, Determine barriers to care by monitoring billing patterns. §, Expand public health insurance coverage; develop a robust interconnected data infrastructure and improve collaborations across federal government bodies; support funding for development of new therapeutics, outreach programs, and retention of minorities in the workforce. †, Support funding for research and development of new therapeutics, population studies, outreach programs, and retention of minorities in the workforce."
}